CPI is a non-profit 501c3 founded and run exclusively on a volunteer basis. CPI coordinates access to medical care and information relating to the treatment of COVID-19. We have gained national and international recognition for our efforts to help save lives by facilitating plasma donations. CPI has partnered with Operation Warp Speed to further antibody treatments.
How it Began
In early April 2020, Abba Swiatycki and Mordy Serle fatefully crossed paths. They were each searching for treatments for acutely ill family members who were fighting for their lives in intensive care units. They were told, independently, that convalescent COVID-19 plasma transfusions could help their relatives in theory, but that the plasma simply wasn't available in their hospitals. Mordy and Abba initiated a campaign to recruit plasma donors, teaming up with Chaim Lebovits, a longtime volunteer patient advocate who had already been independently recruiting donors for a different hospital. Their collective efforts quickly grew into what is now the Covid Plasma Initiative Foundation.
The initiative had historically changed the face of COVID-19 treatment in the USA. Starting as a grassroots effort, with the help of dozens of dedicated volunteers - from project managers to software developers - as well as non-profit organizations and hospitals, CPI launched a robust blood plasma donor network that has recruited several thousands of potential donors to date, and made a profound impact on the limited ways one could treat COVID-19.
The Impact in Treatment
The efforts yielded immediate benefits to hard-hit hospitals in early/mid 2020, which were stretched heroically thin caring for their unprecedented patient loads, and had little access to the lifesaving antibody-rich plasma they desperately needed to treat critically-ill COVID-19 patients.
The initiative had become closely aligned with blood banks, hospitals, non-profits and research centers (including Johns Hopkins, Mayo Clinic, New York Blood Center and many leading hospitals nationwide), and directly continues to impact hospitals' ability to treat coronavirus patients in an unprecedented way, alongside other emerging treatment methods.
Monoclonal Antibody Treatment
In late 2020/early 2021, with the availability of Regeneron's and Eli Lilly's monoclonal antibody treatments available through Operation Warp Speed, CPI stepped in to get access to as many people as possible through concerted efforts of its volunteer team. With a 24/7 call center, relationship-building with many hospitals and infusion centers, and awareness campaigns through social media, CPI is keeping hundreds of patients out of the hospital and avoiding severe illness through this treatment.